However, under pathological conditions that lead to overexpression, disinhibition, and/or dysregulation of MMP-9, its proteolytic activity can lead to blood-brain barrier breakdown, neuroinflammation, and demyelination [7], all of which are processes implicated in the development of AD [9]. This evidence concerns the gene MMP9 and Alzheimer disease.